MOSCARELLA, STEFANIA
 Distribuzione geografica
Continente #
NA - Nord America 1.373
EU - Europa 722
AS - Asia 170
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 2.268
Nazione #
US - Stati Uniti d'America 1.369
SE - Svezia 166
IE - Irlanda 149
PL - Polonia 136
HK - Hong Kong 73
IT - Italia 71
UA - Ucraina 51
CN - Cina 46
RU - Federazione Russa 41
DE - Germania 38
FI - Finlandia 36
SG - Singapore 27
GB - Regno Unito 17
TR - Turchia 15
CH - Svizzera 12
JO - Giordania 6
CA - Canada 4
FR - Francia 4
VN - Vietnam 2
EU - Europa 1
KR - Corea 1
NL - Olanda 1
SC - Seychelles 1
UY - Uruguay 1
Totale 2.268
Città #
Fairfield 214
Dublin 149
Chandler 138
Warsaw 136
Ashburn 114
Woodbridge 96
Jacksonville 85
Cambridge 82
Seattle 74
Houston 71
Wilmington 69
Hong Kong 44
Buffalo 36
Princeton 36
Ann Arbor 31
Beijing 26
Boardman 25
Medford 22
Boston 21
Altamura 17
Lawrence 17
Singapore 15
Izmir 14
Bern 12
Falls Church 10
San Diego 9
Shanghai 9
Washington 8
Bremen 7
Norwalk 7
New York 6
Hillsboro 5
Philadelphia 5
Andover 4
Los Angeles 4
Auburn Hills 3
Catania 3
Frankfurt Am Main 3
Guangzhou 3
London 3
Milan 3
Montalbano Jonico 3
Redmond 3
Toronto 3
Dong Ket 2
Florence 2
Kent 2
Mantova 2
Munich 2
Rome 2
Salerno 2
Taranto 2
Verona 2
Augusta 1
Bologna 1
Bottanuco 1
Chiswick 1
Clifton 1
Dearborn 1
Grevenbroich 1
Montréal 1
Nanjing 1
Phoenix 1
Portland 1
Saint Petersburg 1
Santa Clara 1
Southwark 1
St Petersburg 1
Stanford 1
Tappahannock 1
Terni 1
Wisbech 1
Worcester 1
Zhengzhou 1
Totale 1.684
Nome #
Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis 241
Acute viral hepatitis increases liver stiffness values measured by transient elastography 120
Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C 102
Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation 96
Performance of Doppler ultrasound in the prediction of severe portal hypertension in hepatitis C virus-related chronic liver disease 89
Interferon and thymosin combination therapy in naive patients with chronic hepatitis C. Preliminary results 82
Transient elastography (TE) is more effective for the identification of HCV patients with advanced (F3-F4) rather than significant (F2-F4) liver fibrosis 82
COMBINED PRESENCE OF HCVRNA SEQUENCES AND T(14;18) (q32;q21) TRANSLOCATION IN PBMC FROM PATIENTS WITH CHRONIC HCV INFECTION. 82
COMPARISON BETWEEN HEPATIC VENOUS PRESSURE GRADIENT (HVPG) AND LIVER STIFFNESS MEASUREMENT (LSM) IN PATIENTS WITH HCV-RELATED FIBROSIS/CIRRHOSIS 80
Transient elastography (TE) is more effective for the identification of HCV patients with severe (> F3) rather than significant (> F2) liver fibrosis 78
Hepatic lipid peroxidation and aldehyde dehydrogenase activity in alcoholic and non alcoholic liver disease. 73
Combined presence of HCVRNA sequences and t(14;18) (q32;q21) translocation in PBMC from patients with chronic HCV infection 71
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection 70
Liver stiffness is influenced by a standardized meal in patients with chronic hepatitis C virus at different stages of fibrotic evolution. 69
Regression of T(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 68
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 68
LIVER STIFFNESS MEASUREMENT (LSM) IS ABLE TO PREDICT SEVERE PORTAL HYPERTENSION IN PATIENTS WITH HCV-RELATED ADVANCED CHRONIC LIVER DISEASE 60
Can serum bile acid determination substitute BSP loading test in detecting and monitoring chronic liver diseases? 52
Expired hydrocarbons in patients with chronic liver disease. 51
Regression of T(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 50
Bcl-2 rearranged B cell clones in chronic HCV infection: a possible factor negatively influencing the virological response to treatment 50
Glutatione levels in Drinker's livers 49
Response to IFN-based antiviral therapy and long term effect of HCV eradication in Mixed Cryoglobulinemia, with or without symptoms: a prospective, controlled, open-label, long term, cohort study 48
Efficacia del trattamento antivirale nell’indurre la regressione di cloni B cellulari alberganti la traslocazione t(14;18) nell’infezione cronica da virus C dell’epatite (HCV). 42
Effect of chronic alcoholism on hepatic alcohol-dehydrogenase and aldehyde-dehydrogenase activities in man. 40
L'alcol ed il metabolismo glicidico 39
Effect of antiviral treatment on the prevalence of BCL-2 recombination in HCV infected patients 39
Interferon alfa + Ribavirin (RIBA) therapy for chronic hepatitis C (CHC) patients non responders to interferon alfa monotherapy 37
Metabolismo dell'alcol etilico 36
Alcol e metabolismo proteico 35
Regression of T(14;18) rearing B-cell clones following antiviral therapy in chronic HCV infection 33
Bcl-2 Recombination and Overexpression in HCV-related Mixed Cryoglobulinemia Patients. 31
BCL-2 recombination and overexpression in HCV-related mixed cryoglobulinemia patients. 31
Presence of BCL-2 rearranged B-cell clones in chronic HCV infection may negatively influence virological response to treatment 30
T(14;18) translocation amd BCL-2 overexpression in HCV infection: effects of Interferon and Ribavirin treatment 27
Ruolo dell'elastografia transiente nell'identificazione della fibrosi in pazienti con epatopatia cronica HCV correlata 22
Totale 2.273
Categoria #
all - tutte 7.040
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.040


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020388 0 34 11 35 42 54 47 54 39 28 33 11
2020/2021256 23 20 18 15 5 56 7 19 24 31 18 20
2021/2022252 6 31 12 8 6 9 9 12 10 5 55 89
2022/2023600 60 64 43 33 58 126 88 26 70 5 12 15
2023/2024232 13 25 44 17 12 35 4 57 3 6 5 11
2024/202574 51 23 0 0 0 0 0 0 0 0 0 0
Totale 2.273